查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1372853

蛋白質表徵和鑑定市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品和服務、按應用、最終用途、地區和競爭細分

Protein Characterization and Identification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product & Services, By Application, By End-Use, By Region, and By Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年蛋白質表徵和鑑定市場估值為140.2 億美元，預計到2028 年將以13.65% 的年複合成長率實現顯著成長。這一預測歸因於生物製劑和蛋白質組學領域對蛋白質表徵和鑑定的不斷升級，以及政府對蛋白質體學研究的大量投資，反過來又支持了蛋白質表徵和鑑定行業的擴張。此外，市場的上升軌跡得益於對一系列策略的日益重視，包括推出新穎產品、合作夥伴關係和協同合作，所有這些都有望在整個預測時間內促進大幅成長。

同樣值得注意的是，隨著政府資助，製藥領域的研發支出激增。再加上蛋白質體學領域固有的廣闊前景以及蛋白質技術的不斷進步，共同構成了推動市場在預測期內擴張的關鍵力量。

因此，這些決定因素的累積效應將引導蛋白質表徵和鑑定市場走向強勁成長的軌道，釋放巨大的潛力，並在規定的預測期內建立一個引人注目的模式。

市場概況
預測期 2024-2028
2022 年市場規模 140.2億美元
2028 年市場規模 301.6億美元
2023-2028 年年複合成長率 13.65%
成長最快的細分市場 製藥與生物技術公司
最大的市場 北美洲

慢性病盛行率增加

癌症、糖尿病和心血管疾病等慢性疾病對全球蛋白質表徵和鑑定市場的擴張有重大影響。這些疾病的特徵是蛋白質表現的改變、翻譯後修飾和相互作用，所有這些都為疾病診斷、治療介入和藥物進步提供了寶貴的見解。蛋白質表徵和鑑定過程在破解慢性疾病的分子基礎方面發揮關鍵作用，包括識別疾病特異性生物標記、潛在藥物標靶和複雜途徑。此外，對蛋白質及其相互作用的全面了解也為了解疾病的進展和治療抗藥性的出現提供了寶貴的線索。

個人化醫療需求不斷成長

個人化醫療迅速興起，是一個迅速發展的領域，旨在提供基於患者基因組成、生活方式和其他相關因素的客製化治療。個人化醫療立基於蛋白質表徵和鑑定領域，對全球蛋白質表徵和鑑定市場的擴張產生了深遠的影響。在錯綜複雜的個人化醫療結構中，蛋白質表徵和鑑定發揮著不可或缺的作用，支撐著疾病特異性生物標記的發現和精確客製化的治療干涉措施的發展。透過細緻地揭示蛋白質及其複雜的相互作用，研究人員有能力找出疾病進展過程中纏繞的特定蛋白質，隨後制定選擇性地與這些蛋白質結合的標靶療法。

此外，包括質譜和色譜在內的新型蛋白質組學技術的推動，構成了推動全球蛋白質表徵和鑑定市場成長的動力。這些創新使研究人員在檢查蛋白質方面具有更高的精度和靈敏度，這是個人化醫療發展至關重要的一個方面。

對個人化醫療不斷成長的需求不僅正在塑造其自身的發展軌跡，而且也是引導全球蛋白質表徵和識別市場擴張的重要因素。個人化醫療旨在提供針對患者遺傳體質、生活方式和其他背景因素的獨特治療方法，其基石是蛋白質表徵和鑑定，可作為查明疾病生物標記和製定針對性療法的管道。此外，慢性病盛行率的激增凸顯了對創新、有效療法的需求，從而推動了對蛋白質表徵和鑑定的需求。慢性疾病的特徵是蛋白質表現的變化、翻譯後修飾和複雜的相互作用，為疾病診斷、治療干涉和藥物突破提供了關鍵資料。

蛋白質體學技術的進步

全球蛋白質表徵和鑑定市場的擴張受到蛋白質體技術進步的顯著影響。這些技術包含一系列用於研究給定樣品中蛋白質的配置、操作和相互作用的工具和方法。新型蛋白質組學技術的發展，特別是質譜和色譜法，使研究人員能夠以更高的精度和靈敏度檢查蛋白質。這項進展釋放了在比以前可行的濃度明顯更低的濃度下檢測和測量蛋白質的能力，從而大大拓寬了蛋白質表徵和鑑定的領域。這些技術所表現出的卓越精確度和獨特性是找出疾病特異性生物標記和設計有針對性的治療介入措施的先決條件。

透過應用蛋白質體學技術，研究人員能夠找到有助於疾病進展的不同蛋白質，從而能夠制定選擇性地與這些蛋白質結合的療法。這種以精準醫學為基礎的細緻方法有可能大幅提高患者的治療效果並減輕與傳統治療相關的風險。

此外，蛋白質體學技術在藥物開發領域的應用也推動了全球蛋白質表徵和鑑定市場的成長軌跡。透過剖析蛋白質和潛在候選藥物之間的相互作用，研究人員可以識別具有最佳治療潛力的化合物並完善其藥理學屬性。

同時，對個人化醫療的需求不斷成長，在推動全球蛋白質表徵和鑑定市場的擴張方面發揮關鍵作用。蛋白質體學技術的成熟為識別疾病特異性生物標記和製定標靶治療方法鋪平了道路，這兩者構成了個性化醫療領域的基本組成部分。

更加重視研究和開發

研發 (R&D) 努力的推動力是不可否認的，推動了全球蛋白質表徵和鑑定市場的成長軌跡。隨著對蛋白質表徵和鑑定的需求不斷升級，對能夠提供更快速、更精確和全面的蛋白質分析的創新技術和方法的需求也越來越大。對研發的投入催生了專為蛋白質表徵和鑑定而客製化的新型工具和技術，從而擴大了市場的能力。值得注意的是，質譜、蛋白質微陣列和蛋白質成像方法等開創性蛋白質體學技術的出現，精心策劃了蛋白質分析的變革，使研究人員對蛋白質的複雜性有了前所未有的見解。

這種轉變的一個顯著例子是藥物開發領域，其中蛋白質體學的應用正在迅速成長。許多製藥企業正在大力投資建構蛋白質體驅動的藥物發現平台。此外，蛋白質表徵和鑑定正在向農業、食品科學和環境科學等多個領域取得重大進展。同時，學術和研究機構正在堅定不移地將資源投入研發計劃，推動蛋白質表徵和鑑定的前沿發展。這種熱烈的參與促進了新穎的研究工具、技術和方法的出現，這些工具、技術和方法不僅擴大了市場領域，而且顯著豐富了其成長軌跡。

政府資助的可用性

全球蛋白質表徵和鑑定市場受到政府資助的顯著影響，這是成長的重要動力。資金的提供可以起到多種作用的催化劑，包括支持研究和開發工作、促進新技術的採用以及創新產品和服務的快速商業化。政府資助透過向研究機構和大學提供財政支持而發揮著特別突出的作用。這種支持有助於學術研究，進而為蛋白質表徵和鑑定的新技術和方法的出現鋪平道路。這種催化過程導致新的生物標記的發現和針對多種疾病的針對性治療策略的製定，從而推動市場擴張。

另一方面，政府資助在推動突破性產品和服務的商業化方面發揮關鍵作用。這種金融支持延伸至中小企業（SME），促進其產品的構思和行銷。這種方法不僅有利於新技術和方法的吸收，而且還培養了創新環境。例如，政府資金的支持可以促進新的質譜或色譜儀器的創建，有助於降低分析成本並提高蛋白質鑑定的精確度。

此外，政府資助透過促進學術界、工業界和政府實體之間的合作和夥伴關係來擴大其影響力。這些策略聯盟刺激創新，促進知識交流，並加速開創性技術和方法的開發和商業化。在蛋白質表徵和鑑定市場的宏偉織錦中，政府提供的財政支持錯綜複雜地編織而成，不僅可以促進成長，還可以推動變革性進步的出現。

市場區隔

全球蛋白質表徵和鑑定市場可以根據產品和服務、應用、最終用途和地區進行細分。根據產品和服務，市場可以分為消耗品、儀器和服務。根據應用，市場可分為藥物發現與開發、臨床診斷等。根據最終用途，市場進一步分為製藥和生物技術公司、學術研究機構、合約研究組織等。

市場參與者

Agilent Technologies、Analytik Jena、Bio-Rad Laboratories、Bruker Corporation、Cleaver Scientific、Danaher Corporation、Eurofins Scientific、Horiba、Jeol、Merck KGaA、PerkinElmer Inc、Promega Corporation、Qiagen NV 是全球蛋白質領域的一些領先參與者和表徵市場。

報告範圍：

在本報告中，除了下面詳細介紹的行業趨勢外，全球蛋白質表徵和鑑定市場還分為以下幾類：

蛋白質表徵和鑑定市場，按產品和服務分類：

  • 耗材
  • 儀器
  • 服務儀器

蛋白質表徵與鑑定市場（按應用）：

  • 藥物發現與開發
  • 臨床診斷
  • 其他

蛋白質表徵和鑑定市場，按最終用途：

  • 製藥和生物技術公司
  • 學術研究機構
  • 合約研究組織
  • 其他

蛋白質表徵與鑑定市場（按地區）：

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 南美洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
  • 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

競爭格局

  • 公司簡介：對全球蛋白質表徵和鑑定市場中主要公司的詳細分析。

可用的客製化：

  • 根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球蛋白質表徵與鑑定市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務（消耗品、儀器、服務）
    • 按應用（藥物發現與開發、臨床診斷、其他）
    • 依最終用途（製藥和生物技術公司、學術研究機構、合約研究組織、其他）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按產品和服務
    • 按應用
    • 按最終用途
    • 按地區

第 6 章：北美蛋白質表徵與鑑定市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務（消耗品、儀器、服務）
    • 按應用（藥物發現與開發、臨床診斷、其他）
    • 依最終用途（製藥和生物技術公司、學術研究機構、合約研究組織、其他）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲蛋白質表徵與鑑定市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務（消耗品、儀器、服務）
    • 按應用（藥物發現與開發、臨床診斷、其他）
    • 依最終用途（製藥和生物技術公司、學術研究機構、合約研究組織、其他）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區蛋白質表徵與鑑定市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務（消耗品、儀器、服務）
    • 按應用（藥物發現與開發、臨床診斷、其他）
    • 依最終用途（製藥和生物技術公司、學術研究機構、合約研究組織、其他）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲蛋白質表徵與鑑定市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務（消耗品、儀器、服務）
    • 按應用（藥物發現與開發、臨床診斷、其他）
    • 依最終用途（製藥和生物技術公司、學術研究機構、合約研究組織、其他）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲蛋白質表徵和鑑定市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務（消耗品、儀器、服務）
    • 按應用（藥物發現與開發、臨床診斷、其他）
    • 依最終用途（製藥和生物技術公司、學術研究機構、合約研究組織、其他）
    • 按國家/地區
  • MEA：國家分析
    • 南非蛋白質表徵和鑑定
    • 沙烏地阿拉伯蛋白質表徵和鑑定
    • 阿拉伯聯合大公國蛋白質表徵和鑑定

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球蛋白質表徵與鑑定市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Agilent Technologies
    • Analytik Jena
    • Bio-Rad Laboratories
    • Bruker Corporation
    • Cleaver Scientific
    • Danaher Corporation
    • Eurofins Scientific
    • Horiba
    • Jeol
    • Merck KGaA
    • PerkinElmer Inc
    • Promega Corporation
    • Qiagen NV

第 16 章：策略建議

簡介目錄
Product Code: 15523

Protein characterization and Identification market was valued at USD 14.02 Billion in 2022, and is poised for remarkable growth with a CAGR Of 13.65% by 2028. This projection is attributable to the escalating embrace of protein characterization and identification within the biologics and proteomics sectors, complemented by substantial investments by governments in proteomics research, which in turn buttresses the expansion of the protein characterization and identification industry. Furthermore, the market's upward trajectory gains momentum from the increasing emphasis on a spectrum of strategies, including the introduction of novel products, collaborative partnerships, and synergistic collaborations, all of which are poised to foster substantial growth throughout the forecast timeframe.

Equally noteworthy is the surge in research and development expenditure within the pharmaceutical domain, in tandem with governmental funding. This, coupled with the promising prospects inherent in the proteomics field and the ongoing advancements in protein technology, collectively constitute pivotal forces propelling the market's expansion over the forecast duration.

Consequently, the cumulative effect of these determinants is set to steer the protein characterization and identification market toward a trajectory of robust growth, unlocking considerable potential and establishing a striking landscape within the stipulated forecast period.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 14.02 Billion
Market Size 2028USD 30.16 Billion
CAGR 2023-202813.65%
Fastest Growing SegmentPharmaceutical & Biotechnology Companies
Largest MarketNorth America

Increasing prevalence of chronic diseases

Chronic ailments, such as cancer, diabetes, and cardiovascular disorders, wield a substantial influence over the expansion of the Global Protein Characterization and Identification Market. These conditions are distinguished by alterations in protein expression, post-translational modifications, and interactions, all of which proffer valuable insights for disease diagnosis, therapeutic interventions, and pharmaceutical advancement. The process of protein characterization and identification plays a pivotal role in deciphering the molecular underpinnings of chronic ailments, encompassing the discernment of disease-specific biomarkers, potential drug targets, and intricate pathways. Moreover, the comprehensive understanding of proteins and their interplay also furnishes invaluable glimpses into the progression of maladies and the emergence of resistance to treatments.

The escalating prevalence of chronic diseases underscores the heightened demand for protein characterization and identification. According to the World Health Organization (WHO), chronic ailments account for 71% of global fatalities, and this figure is poised to surge in the years ahead. This escalating burden imposed by chronic diseases has triggered a call for novel and efficacious therapies, consequently escalating the requisition for protein characterization and identification.

Furthermore, the burgeoning aspiration for personalized medicine contributes to the burgeoning growth of the global Protein Characterization and Identification market. Personalized medicine strives to deliver tailored treatments based on a patient's genetic composition, lifestyle, and other influencing factors. The process of protein characterization and identification occupies a vital role in sculpting personalized medicine's landscape, offering a platform for the identification of disease-specific biomarkers and the formulation of precisely targeted therapies.

Growing demand for personalized medicine

Emerging at a swift pace, personalized medicine stands as a rapidly burgeoning realm, geared toward furnishing customized treatment grounded in a patient's genetic composition, lifestyle, and other relevant factors. Anchored in the domain of protein characterization and identification, personalized medicine exerts a profound influence on the expansion of the global Protein Characterization and Identification market. In the intricate tapestry of personalized medicine's fabric, protein characterization and identification play an indispensable role, underpinning the discovery of disease-specific biomarkers and the formulation of precisely tailored therapeutic interventions. Through the meticulous unraveling of proteins and their intricate interplays, researchers are endowed with the capability to pinpoint particular proteins entwined in the course of disease progression, subsequently forging targeted therapies that selectively engage with these proteins.

Moreover, the propulsion of novel proteomic technologies, including mass spectrometry and chromatography, constitutes a dynamic force driving the growth of the global Protein Characterization and Identification market. These innovations equip researchers with heightened precision and sensitivity in scrutinizing proteins, an aspect of paramount importance in the evolution of personalized medicine.

The escalating demand for personalized medicine is not only shaping its own trajectory but is also an instrumental factor steering the expansion of the Global Protein Characterization and Identification Market. Aiming to deliver treatments uniquely molded to a patient's genetic constitution, lifestyle, and other contextual elements, personalized medicine finds its cornerstone in protein characterization and identification, serving as a conduit to pinpointing disease biomarkers and honing targeted remedies. Additionally, the surging prevalence of chronic diseases casts a spotlight on the demand for innovative, efficacious therapies, thus fanning the need for protein characterization and identification. Chronic illnesses, hallmarked by shifts in protein expression, post-translational modifications, and intricate interactions, proffer a reservoir of pivotal data for disease diagnosis, therapeutic interventions, and pharmaceutical breakthroughs.

Advancements in proteomic technologies

The expansion of the global Protein Characterization and Identification market has been significantly influenced by the strides achieved in proteomic technologies. These technologies encompass an array of tools and methodologies employed to investigate the configuration, operation, and interplays of proteins within a given sample. The evolution of novel proteomic technologies, notably exemplified by mass spectrometry and chromatography, has empowered researchers to scrutinize proteins with heightened precision and sensitivity. This progression has unleashed the capacity to detect and gauge proteins at markedly lower concentrations than previously feasible, thereby substantially broadening the realm of protein characterization and identification. The exceptional precision and distinctiveness exhibited by these technologies stand as prerequisites for pinpointing disease-specific biomarkers and engineering targeted therapeutic interventions.

Through the application of proteomic technologies, researchers are endowed with the means to pinpoint distinct proteins that contribute to the advancement of diseases, enabling the formulation of therapies that selectively engage with these proteins. This meticulous approach, anchored in precision medicine, bears the potential to profoundly elevate patient outcomes and alleviate the risks associated with conventional treatments.

Moreover, the utilization of proteomic technologies in the domain of drug development has also propelled the growth trajectory of the Global Protein Characterization and Identification Market. By dissecting the interactions between proteins and potential drug candidates, researchers can discern compounds boasting optimal therapeutic potential and refine their pharmacological attributes.

Simultaneously, the surging demand for personalized medicine plays a pivotal role in steering the expansion of the global Protein Characterization and Identification market. The maturation of proteomic technologies has paved the way for the identification of disease-specific biomarkers and the formulation of targeted therapeutic approaches, both of which constitute fundamental components of personalized medicine's landscape.

Increasing focus on research and development

Driving the growth trajectory of the global Protein Characterization and Identification market, the impetus stemming from research and development (R&D) endeavors is undeniable. As the demand for protein characterization and identification escalates, the imperative for inventive technologies and methodologies intensifies, ones capable of delivering swifter, more precise, and all-encompassing protein analyses. The infusion of investments into R&D pursuits has engendered the emergence of novel tools and techniques tailor-made for protein characterization and identification, thereby amplifying the market's capabilities. Notably, the advent of pioneering proteomic technologies such as mass spectrometry, protein microarrays, and protein imaging methods has orchestrated a transformation in protein analysis, granting researchers unprecedented insights into protein intricacies.

A striking illustration of this transformation lies in the sphere of drug development, wherein the employment of proteomics is rapidly gaining momentum. Numerous pharmaceutical enterprises are making substantial investments in the crafting of proteomic-driven drug discovery platforms. Furthermore, protein characterization and identification are making substantial inroads into diverse sectors including agriculture, food science, and environmental science. Concurrently, academic and research institutions are steadfastly channeling resources into R&D initiatives, propelling the frontiers of protein characterization and identification. This fervent engagement has fostered the emergence of novel research tools, technologies, and methodologies that have not only expanded the market's realm but have also markedly enriched its growth trajectory.

Availability of government funding

The global Protein Characterization and Identification market experiences a notable influence from government funding, signifying a significant driver of growth. The availability of funding serves as a catalyst for manifold effects, including the bolstering of research and development endeavors, the facilitation of new technology adoption, and the expeditious commercialization of innovative products and services. Government funding exercises a particularly prominent role by providing financial backing to research institutions and universities. This support aids academic research, which in turn paves the way for the emergence of novel technologies and methodologies geared toward protein characterization and identification. This catalytic process leads to the unearthing of fresh biomarkers and the formulation of targeted therapeutic strategies across a diverse spectrum of ailments, thereby propelling market expansion.

Government funding, in another vein, plays a pivotal part in propelling the commercialization of groundbreaking products and services. Such financial support extends to small and medium-sized enterprises (SMEs), facilitating the conception and marketing of their offerings. This approach not only eases the assimilation of novel technologies and methodologies but also nurtures an environment of innovation. For instance, the backing of government funding can precipitate the creation of new mass spectrometry or chromatography instruments, thereby contributing to reduced analysis costs and heightened precision in protein identification.

Furthermore, government funding extends its influence by fostering collaborations and partnerships among academia, industry, and government entities. These strategic alliances spur innovation, foster the exchange of knowledge, and expedite the development and commercialization of pioneering technologies and approaches. In the grand tapestry of the Protein Characterization and Identification market, the financial support provided by governments intricately weaves a fabric that not only catalyzes growth but also fuels the emergence of transformative advancements.

Market Segmentation

Global Protein Characterization and Identification market can be segmented on the basis of product and service, application, end use and by region. Based on the product and service, the market can be segmented into consumables, instruments, and services. Based on application, the market can be segmented into drug discovery & development, clinical diagnosis, and others. Based on end use, the market is further divided into pharmaceuticals & biotechnology companies, academic research institutes, contract research organizations, and others.

Market Players

Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, Bruker Corporation, Cleaver Scientific, Danaher Corporation, Eurofins Scientific, Horiba, Jeol, Merck KGaA, PerkinElmer Inc, Promega Corporation, Qiagen NV are some of the leading players operating in the global Protein Characterization and Identification market.

Report Scope:

In this report, global Protein Characterization and Identification market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Characterization and Identification Market, By Product and Service:

  • Consumables
  • Instruments
  • Services Instruments

Protein Characterization and Identification Market, By Application:

  • Drug Discovery & Development
  • Clinical Diagnosis
  • Others

Protein Characterization and Identification Market, By End Use:

  • Pharmaceuticals & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Others

Protein Characterization and Identification Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the global Protein Characterization and Identification market.

Available Customizations:

  • With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Characterization and Identification Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Services (Consumables, Instruments, Services)
    • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product & Services
    • 5.3.2 By Application
    • 5.3.3 By End Use
    • 5.3.4 By Region

6. North America Protein Characterization and Identification Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Services (Consumables, Instruments, Services)
    • 6.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 6.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Protein Characterization and Identification Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Protein Characterization and Identification Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Protein Characterization and Identification Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End Use

7. Europe Protein Characterization and Identification Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Services (Consumables, Instruments, Services)
    • 7.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 7.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Protein Characterization and Identification Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End Use
    • 7.3.2. Germany Protein Characterization and Identification Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Protein Characterization and Identification Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Protein Characterization and Identification Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Protein Characterization and Identification Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End Use

8. Asia-Pacific Protein Characterization and Identification Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Services (Consumables, Instruments, Services)
    • 8.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 8.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Protein Characterization and Identification Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Protein Characterization and Identification Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Protein Characterization and Identification Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Protein Characterization and Identification Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Protein Characterization and Identification Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End Use

9. South America Protein Characterization and Identification Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Services (Consumables, Instruments, Services)
    • 9.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 9.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Protein Characterization and Identification Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End Use
    • 9.3.2. Argentina Protein Characterization and Identification Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End Use
    • 9.3.3. Colombia Protein Characterization and Identification Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End Use

10. Middle East and Africa Protein Characterization and Identification Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Services (Consumables, Instruments, Services)
    • 10.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 10.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Protein Characterization and Identification Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End Use
    • 10.3.2. Saudi Arabia Protein Characterization and Identification Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End Use
    • 10.3.3. UAE Protein Characterization and Identification Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Protein Characterization and Identification Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Agilent Technologies
    • 15.6.2 Analytik Jena
    • 15.6.3 Bio-Rad Laboratories
    • 15.6.4 Bruker Corporation
    • 15.6.5 Cleaver Scientific
    • 15.6.6 Danaher Corporation
    • 15.6.7 Eurofins Scientific
    • 15.6.8 Horiba
    • 15.6.9 Jeol
    • 15.6.10 Merck KGaA
    • 15.6.11 PerkinElmer Inc
    • 15.6.12 Promega Corporation
    • 15.6.13 Qiagen NV

16. Strategic Recommendations